Page last updated: 2024-08-24

adenosine and Adenocarcinoma of Lung

adenosine has been researched along with Adenocarcinoma of Lung in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (11.54)	24.3611
2020's	23 (88.46)	2.80

Authors

Authors	Studies
Li, Q; Wang, C; Xiong, Y; Yang, X; Zhang, D; Zhang, R	1
Guo, M; Li, Z; Ming, L; Qin, Z; Wan, J; Wang, Y; Yang, Z; Zhao, Z; Zheng, J	1
Bai, Z; Wu, X	1
Bao, F; Chu, X; Feng, L; Sun, Z; Wang, W	1
Chen, B; Hu, Z; Zhang, Y; Zhu, L	1
Ding, H; Gao, C; Kong, N; Li, J; Sun, Z; Tang, T; Wu, L; Xu, M; Zhang, F	1
Huang, T; Ye, W	1
Cui, J; Du, X; Ke, J; Ma, B; Yang, X; Yu, L	1
Bai, L; Chen, Q; Hu, CP; Jiang, J; Li, YY; Wan, RJ; Zhang, Y; Zhao, BR	1
Huang, Y; Ma, M; Wang, B; Wang, W; Yang, Y; Ye, L; Zhao, G	1
Ge, H; Jin, L; Wang, N; Wang, X; Wang, Y; Wu, S; Xu, Y; Zhao, J; Zhou, F	1
Cai, X; Zhang, X	1
Chen, KJ; Gu, DL; Ho, CM; Hsiao, CH; Hsu, YH; Huang, JH; Jen, HW; Jou, YS; Kung, YC; Lang, YD; Lee, HY; Lee, SS; Shen, R; Shih, JH; Wu, CY	1
Cai, Y; Guo, MM; Li, Y; Liu, MY; Ming, DJ; Wang, DQ; Wang, SY; Xi, S; Yuan, S; Zhang, JH; Zhang, YJ	1
Fu, N; Teng, Y; Xi, Y; Zhao, X	1
Chao, Y; Ji, W; Shang, J	1
Hu, Q; Li, J; Liu, L; Liu, X; Sun, R; Zhang, Y	1
Hu, D; Wang, M; Zhu, J	1
Xie, Y; Zhao, W	1
Akbay, EA; Behrens, C; Bernatchez, C; Byers, LA; Chen, R; Diao, L; Elamin, Y; Fan, YH; Federico, L; Gibbons, DL; Haymaker, C; Heymach, JV; Kadara, H; Karpinets, T; Khairullah, R; Le, X; Lee, WC; Li, J; McGrail, D; Munoz, IG; Negrao, MV; Nilsson, M; Parra, E; Patel, S; Reuben, A; Robichaux, J; Roth, J; Sepesi, B; Solis Soto, LM; Swisher, S; Vaporciyan, A; Wang, J; Wang, L; Wang, R; Wistuba, II; Wong, KK; Zhang, J; Zhu, M	1
Feng, F; Gao, C; Li, H; Liu, C; Liu, L; Sun, C; Zhou, C; Zhuang, J	1
Chang, N; Che, Y; Jiang, J; Qiao, T; Wu, B; Wu, Y; Xiong, J; Xu, L; Zhang, J; Zhang, X; Zhang, Y; Zhou, Y	1
Huang, Z; Shi, J; Shi, M; Wang, J; Zhang, H; Zheng, M; Zhou, H; Zhou, Y	1
Ahmed, M; Gao, S; Guan, J; Guo, H; He, HH; Hua, JT; Moran, MF; Soares, F; Tsao, MS; Wang, M; Wang, S; Zeng, Y	1
Behrens, C; Coombes, KR; Girard, L; Heymach, J; Hong, WK; Lee, JJ; Lin, HY; Minna, JD; Nilsson, MB; Riquelme, E; Simon, G; Suraokar, M; Wang, J; Wistuba, II	1
Balzarini, J; Peterson, MA; Shelton, JR	1

Trials

1 trial(s) available for adenosine and Adenocarcinoma of Lung

Article	Year
Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification. BMC medical genomics, 2022, 01-29, Volume: 15, Issue:1 Topics: Adenocarcinoma of Lung; Adenosine; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Nomograms; Risk Assessment; RNA, Long Noncoding	2022

Other Studies

25 other study(ies) available for adenosine and Adenocarcinoma of Lung

Article	Year
Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2022, 07-01, Volume: 31, Issue:4 Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Lung Neoplasms; Methyltransferases; Prognosis	2022
N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment. Journal of clinical laboratory analysis, 2021, Volume: 35, Issue:11 Topics: Adenocarcinoma of Lung; Adenosine; Aged; Computational Biology; DNA Methylation; Female; Humans; Lung Neoplasms; Male; Middle Aged; RNA, Long Noncoding; Transcriptome; Tumor Microenvironment	2021
Multi-omics analysis of m Scientific reports, 2021, 10-22, Volume: 11, Issue:1 Topics: Adenocarcinoma of Lung; Adenosine; Aged; Biomarkers, Tumor; CTLA-4 Antigen; Female; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Prognosis; Tumor Microenvironment	2021
An N Mathematical biosciences and engineering : MBE, 2022, Volume: 19, Issue:1 Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms	2022
N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1. Bioengineered, 2022, Volume: 13, Issue:2 Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Proliferation; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Proteins; Methyltransferases; Microfilament Proteins; RNA Stability; RNA, Antisense; RNA, Long Noncoding; Tumor Cells, Cultured	2022
Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma. PloS one, 2022, Volume: 17, Issue:2 Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Methylation; RNA; RNA Processing, Post-Transcriptional; Tumor Microenvironment	2022
[Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2022, May-20, Volume: 25, Issue:5 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Methylation; Tumor Microenvironment	2022
N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma. Gene, 2022, Aug-20, Volume: 836 Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Tumor Microenvironment	2022
The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma. Cellular and molecular biology (Noisy-le-Grand, France), 2022, May-22, Volume: 68, Issue:1 Topics: Adenocarcinoma of Lung; Adenosine; Animals; Humans; Lung Neoplasms; Mammals; Prognosis; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering	2022
Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma. Disease markers, 2022, Volume: 2022 Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antigens, CD; Humans; Lung Neoplasms; Lymphocyte Activation Gene 3 Protein; Prognosis; RNA-Binding Proteins; Tumor Microenvironment; Ubiquitin-Protein Ligases	2022
Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma. Medicine, 2022, Nov-11, Volume: 101, Issue:45 Topics: Adenocarcinoma of Lung; Adenosine; Cell Cycle Proteins; Humans; Lung Neoplasms; Methyltransferases; RNA Splicing Factors; RNA-Binding Proteins; Transcription Factors	2022
Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma. Molecular carcinogenesis, 2023, Volume: 62, Issue:3 Topics: Adenocarcinoma of Lung; Adenosine; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Guanosine Triphosphate; Humans; Inosine; Lung Neoplasms; Mutation; Protein Isoforms; Proteomics; rhoA GTP-Binding Protein; RNA	2023
Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer. Cell death & disease, 2023, 06-13, Volume: 14, Issue:6 Topics: Adenocarcinoma of Lung; Adenosine; Cell Nucleus; Down-Regulation; Humans; Lung Neoplasms	2023
N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker. Cancer biology & therapy, 2023, 12-31, Volume: 24, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Biomarkers; Humans; Lung Neoplasms; Prognosis	2023
ALKBH5-m Biochemical and biophysical research communications, 2020, 01-08, Volume: 521, Issue:2 Topics: Adenocarcinoma of Lung; Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Cell Proliferation; Forkhead Box Protein M1; Humans; Hypoxia; Lung Neoplasms; Mice; Neoplasm Invasiveness; Signal Transduction	2020
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma. Medical science monitor : international medical journal of experimental and clinical research, 2020, Feb-22, Volume: 26 Topics: Adenocarcinoma of Lung; Adenosine; Cohort Studies; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Prognosis; RNA, Messenger	2020
Deciphering N BioMed research international, 2020, Volume: 2020 Topics: Adenocarcinoma of Lung; Adenosine; AlkB Homolog 5, RNA Demethylase; Biomarkers, Tumor; Disease-Free Survival; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Kaplan-Meier Estimate; Male; Methyltransferases; Multivariate Analysis; Neoplasm Staging; Prognosis; RNA Helicases; RNA-Binding Proteins; RNA-Seq; Transcriptome	2020
KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A. Pathology, research and practice, 2021, Volume: 217 Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Movement; Cell Proliferation; Databases, Genetic; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methylation; Middle Aged; Mucin-3; Neoplasm Invasiveness; Neoplasm Staging; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; Signal Transduction; Tumor Burden	2021
Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021, Volume: 16, Issue:4 Topics: Adenocarcinoma of Lung; Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Lung Neoplasms; Mice; Mutation; Tumor Microenvironment	2021
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database. Aging, 2021, 01-10, Volume: 13, Issue:3 Topics: Adenocarcinoma of Lung; Adenosine; Databases, Genetic; DNA Copy Number Variations; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Risk Assessment; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome	2021
METTL3-mediated m Journal of experimental & clinical cancer research : CR, 2021, Mar-06, Volume: 40, Issue:1 Topics: Adenocarcinoma of Lung; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; F-Box-WD Repeat-Containing Protein 7; Heterografts; Humans; Lung Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Messenger	2021
Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. BMC cancer, 2021, Aug-20, Volume: 21, Issue:1 Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Methylation; Prognosis; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome; Tumor Microenvironment	2021
Refined RIP-seq protocol for epitranscriptome analysis with low input materials. PLoS biology, 2018, Volume: 16, Issue:9 Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Antibodies; Base Sequence; Gene Expression Profiling; Humans; Immunoprecipitation; RNA	2018
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-15, Volume: 20, Issue:14 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Mice, Nude; MicroRNAs; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2014
Discovery of a nanomolar inhibitor of lung adenocarcinoma in vitro. Bioorganic & medicinal chemistry letters, 2014, Nov-01, Volume: 24, Issue:21 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Antineoplastic Agents; Binding Sites; Bone Morphogenetic Protein Receptors, Type I; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Lung Neoplasms; Molecular Docking Simulation; Structure-Activity Relationship	2014